Abstract:OBJECTIVE:To establish a simple, rapid and easy method for screening the gene mutation in hemophilia A, which was further applied to a direct diagnosis and carrier detection at gene level.METHODS:Twenty-four clinically diagnosed hemophilia pedigrees, including all the hemophilia patients and female members, were tested for the introns 22 and 1 in factor VIII gene by using inversion polymerase chain reaction (PCR) and regular PCR techniques. All the 26 exons of factor VIII gene were consecutively screened in the 17 patients manifesting non-inverted sequences in intron 22 by using PCR, subsequently all the 37 amplicons resulted from 26 exons were analyzed by conformation sensitive gel electrophoresis (CSGE), finally the mutated exons were subjected to sequencing verification. According to the mutation results, mothers and twin sisters of the hemophilia probands were tested by CSGE or subjected to nucleotide sequencing directly, to ascertain if those individuals had the same mutation or were the carriers of disease-causing gene.RESULTS:Intron 22 inversion was detected in 7 hemophilia probands out of 24 hemophilia pedigrees, intron 1 inversion was not detected in these pedigrees. Single-base mutations distributed in different exons of factor VIII gene were detected in 13 pedigrees with family history and 3 sporadic pedigrees, diagnosed as non-inverted 22 intron patients. By comprehensive usage of PCR-CSGE and nucleotide sequencing, the positive rate and the diagnosable rate of gene diagnosis or carrier detection in the 24 hemophilia pedigrees was 94.12% and 100% respectively.CONCLUSION:PCR-CSGE is a highly sensitive and special assay for detecting single base mutation. By integrated utilization of introns 22 and 1 of factor VIII gene detection and PCR-CSGE genotyping, combining with nucleotide sequencing, a direct diagnosis of all hemophilia pedigrees be could nearly make at gene level, including the sporadic families. This method might be used to screen new mutation theoretically and ascertain the mutation type. It is a simple, rapid and low-cost method, possessing unique advantages in direct diagnosis of hemophilia A and carrier screening. It should have important application value in hemophilia diagnosis.

Prenatal Diagnosis in Hemophilia A by Fetal Blood Sampling

Carrier Detection and Prenatal Diagnosis of Hemophilia A.

Direct Sequencing in Hemophilia A Carrier Diagnosis and Prenatal Diagnosis

Carrier detection and prenatal diagnosis of haemophilia

Genetic diagnosis of hemophilia A families with no proband

A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing.

Detection of FⅧ Gene Intron 22 and 1 Inversion Using Inversion-PCR Assay in Hemophilia A

[Application Studies on the Gene Diagnosis and Carrier Detection of Hemophilia A by Using Polymerase Chain Reaction-Conformation Sensitive Gel Electrophoresis].

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders

Quantitative Analysis of Fetal RhD Genotyping with Fetal DNA from RhD-negative Maternal Plasma

Single Cell Four-Plex Nested Fluorescent PCR for Hemophilia A Genetic Diagnosis and Gender Determination

Prenatal diagnosis of fetomaternal hemorrhage by a novel hydrogel fluoroimmunoassay that accurately quantifies fetal haemoglobin

Diagnosis and therapy of Rh(D) hemolytic diseases caused by maternal-fetal blood group incompatibility.

The status of carrier and prenatal diagnosis of haemophilia in China.

Prenatal Determination of Fetal RhD Genotype by Real-Time PCR Examination of Fetal DNA in Maternal Plasma

[Mutation screening of the F VIII gene in 10 hemophilia A families].

Detection of hemophilia A genetic variants using third-generation long-read sequencing

Genetic Counseling in Two Particular Hemophilia A Families

Invasive Molecular Prenatal Diagnosis of Alpha and Beta Thalassemia among Hakka Pregnant Women

Gene diagnosis of co-existed hemophilia A and B in a pedigree

Detection of fetal RHD genotyping with fetal DNA from RhD-negative maternal plasma